---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-002048"
form_type: "8-K"
ticker: "SIGY"
cik: "0001642159"
company_name: "Sigyn Therapeutics, Inc."
filed_at: "2024-01-11T23:59:59+00:00"
generated_at: "2026-06-07T00:34:28.441645+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Sigyn Therapeutics enters share surrender agreement with CTO to cancel 2.56M shares

## Summary
- Craig Roberts, CTO and board member, surrenders 2,564,000 shares of common stock for cancellation.
- Shares are cancelled and not held as treasury shares; no further claims against the company.
- As of Jan 9, 2024, total outstanding shares are 48,972,602 following this surrender and note conversions.

## SEC filing metadata
- accession: 0001493152-24-002048
- form_type: 8-K
- ticker: SIGY
- cik: 0001642159
- company_name: Sigyn Therapeutics, Inc.
- filed_at: 2024-01-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642159/000149315224002048/0001493152-24-002048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642159/000149315224002048/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-002048
- JSON: https://secwatch.observer/filing/0001493152-24-002048.json
- Plain text: https://secwatch.observer/filing/0001493152-24-002048.txt

## Key facts
- Material Agreements
  Sigyn Therapeutics, Inc. entered into Share Surrender Agreement with Craig Roberts (effective 2024-01-09).
  - Action: entry
  - Counterparty: Craig Roberts
  - Effective: 2024-01-09
  source text: On January 9, 2024, Sigyn Therapeutics, Inc. (the “Company”) entered into a Share Surrender Agreement with Craig Roberts, Chief Technical Officer and member of the board of directors of the Company (the “Shareholder”), whereas the parties agreed that 2,564,000 shares of common stock, par value $0.001, shall be surrendered by the Shareholder to the Company for cancellation and shall subsequently not be held as treasury shares or represent any claim against the Company whatsoever, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1642159/000149315224002048/0001493152-24-002048-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.